110 related articles for article (PubMed ID: 36001064)
1. Somatic ablation of IKKβ in liver and leukocytes is not tolerated in obese mice but hepatic IKKβ deletion improves fatty liver and insulin sensitivity.
Silva VRR; Molinaro A; Gaudi AU; Fryk E; Sardi C; Hammarlund M; Mjörnstedt F; Johansson ME; Becattini B; Jansson PA; Solinas G
FASEB J; 2022 Sep; 36(9):e22512. PubMed ID: 36001064
[TBL] [Abstract][Full Text] [Related]
2. XBP1s Is an Anti-lipogenic Protein.
Herrema H; Zhou Y; Zhang D; Lee J; Salazar Hernandez MA; Shulman GI; Ozcan U
J Biol Chem; 2016 Aug; 291(33):17394-404. PubMed ID: 27325692
[TBL] [Abstract][Full Text] [Related]
3. Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction.
Liu J; Ibi D; Taniguchi K; Lee J; Herrema H; Akosman B; Mucka P; Salazar Hernandez MA; Uyar MF; Park SW; Karin M; Ozcan U
Cell; 2016 Nov; 167(4):1052-1066.e18. PubMed ID: 27814504
[TBL] [Abstract][Full Text] [Related]
4. Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
Wang XA; Zhang R; She ZG; Zhang XF; Jiang DS; Wang T; Gao L; Deng W; Zhang SM; Zhu LH; Guo S; Chen K; Zhang XD; Liu DP; Li H
Hepatology; 2014 Mar; 59(3):870-85. PubMed ID: 24123166
[TBL] [Abstract][Full Text] [Related]
5. Hepatic p63 regulates steatosis via IKKβ/ER stress.
Porteiro B; Fondevila MF; Delgado TC; Iglesias C; Imbernon M; Iruzubieta P; Crespo J; Zabala-Letona A; Fernø J; González-Terán B; Matesanz N; Hernández-Cosido L; Marcos M; Tovar S; Vidal A; Sánchez-Ceinos J; Malagon MM; Pombo C; Zalvide J; Carracedo A; Buque X; Dieguez C; Sabio G; López M; Aspichueta P; Martínez-Chantar ML; Nogueiras R
Nat Commun; 2017 May; 8():15111. PubMed ID: 28480888
[TBL] [Abstract][Full Text] [Related]
6. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice.
Caracciolo V; Young J; Gonzales D; Ni Y; Flowers SJ; Summer R; Waldman SA; Kim JK; Jung DY; Noh HL; Kim T; Blackshear PJ; O'Connell D; Bauer RC; Kallen CB
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E676-E693. PubMed ID: 29509432
[TBL] [Abstract][Full Text] [Related]
8. FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways.
Jiao P; Ma J; Feng B; Zhang H; Diehl JA; Chin YE; Yan W; Xu H
Obesity (Silver Spring); 2011 Mar; 19(3):483-91. PubMed ID: 20829802
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Mc1 improves liver steatosis and insulin resistance by attenuating ER stress.
Roh E; Hwang HJ; Kim JW; Hong SH; Kim JA; Lee YB; Choi KM; Baik SH; Yoo HJ
J Ethnopharmacol; 2020 Sep; 259():112927. PubMed ID: 32387461
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of IKKβ in adipose tissue prevents diet-induced obesity in mice.
Jiao P; Feng B; Ma J; Nie Y; Paul E; Li Y; Xu H
Endocrinology; 2012 Jan; 153(1):154-65. PubMed ID: 22067324
[TBL] [Abstract][Full Text] [Related]
11. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
[TBL] [Abstract][Full Text] [Related]
12. The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis.
Heida A; Gruben N; Catrysse L; Koehorst M; Koster M; Kloosterhuis NJ; Gerding A; Havinga R; Bloks VW; Bongiovanni L; Wolters JC; van Dijk T; van Loo G; de Bruin A; Kuipers F; Koonen DPY; van de Sluis B
Mol Metab; 2021 Dec; 54():101349. PubMed ID: 34626855
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of electroacupuncture in improving obesity-induced insulin resistance via TLR4/NF-κB inflammatory pathway in liver].
Lu W; Wu S; Li J; Wang YY; Zhou YD; Liang FX
Zhen Ci Yan Jiu; 2022 Jun; 47(6):504-9. PubMed ID: 35764517
[TBL] [Abstract][Full Text] [Related]
14. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
15. Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.
Anhê FF; Varin TV; Le Barz M; Pilon G; Dudonné S; Trottier J; St-Pierre P; Harris CS; Lucas M; Lemire M; Dewailly É; Barbier O; Desjardins Y; Roy D; Marette A
Diabetologia; 2018 Apr; 61(4):919-931. PubMed ID: 29270816
[TBL] [Abstract][Full Text] [Related]
16. Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation.
Dong H; Huang H; Yun X; Kim DS; Yue Y; Wu H; Sutter A; Chavin KD; Otterbein LE; Adams DB; Kim YB; Wang H
Endocrinology; 2014 Mar; 155(3):818-28. PubMed ID: 24424052
[TBL] [Abstract][Full Text] [Related]
17. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
18. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.
Wang J; Chakrabarty S; Bui Q; Ruf W; Samad F
Am J Pathol; 2015 Feb; 185(2):524-35. PubMed ID: 25476527
[TBL] [Abstract][Full Text] [Related]
20. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
Perfield JW; Lee Y; Shulman GI; Samuel VT; Jurczak MJ; Chang E; Xie C; Tsichlis PN; Obin MS; Greenberg AS
Diabetes; 2011 Apr; 60(4):1168-76. PubMed ID: 21346175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
